Envoy Medical, Inc.Financials
|
|
Historical Financials
DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | 241,000 | 225,000 | 316,000 | 237,000 | 0 | 0 | |
| Cost of Revenue | 874,000 | 742,000 | 789,000 | 498,000 | 0 | 0 | |
| Gross Profit | -633,000 | -517,000 | -473,000 | -261,000 | 0 | 0 |
Sign up to view full financial statements
Create a free CapEdge account to access balance sheet, cash flow, and complete historical data.
DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | ||
|---|---|---|---|---|---|---|---|
| Gross Profit Margin (%) | |||||||
| R&D Expense | |||||||
| SG&A Expense | |||||||
| Total Operating Expenses | |||||||
| Operating Income or Loss | |||||||
| Operating Margin (%) | |||||||
| EBITDA | |||||||
| Non-Operating Income/Expense | |||||||
| Income Before Tax | |||||||
| Income Tax Expense | |||||||
| Income from Continuing Ops. | |||||||
| Net Income | |||||||
| Net Profit Margin (%) | |||||||
| Basic EPS | |||||||
| Diluted EPS | |||||||
| Basic Average Shares | |||||||
| Diluted Average Shares |
All numbers in thousands. Financial statements are in beta and sourced from EDGAR XBRL filings. Read the caveats.